Global High Intensity Focused Ultrasound (HIFU) Market – Industry Trends and Forecast to 2030

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global High Intensity Focused Ultrasound (HIFU) Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Jul 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Table of Content

1. INTRODUCTION

 

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

 

2. MARKET SEGMENTATION

 

2.1 KEY TAKEAWAYS

 

2.2 ARRIVING AT THE GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET SIZE

 

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS 

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES

 

2.3 GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

 

3. MARKET OVERVIEW

 

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

 

4. EXECUTIVE SUMMARY

 

5. PREMIUM INSIGHTS

 

5.1 PORTER’S 5 FORCES

5.2 PESTEL ANALYSIS

6. INDUSTRY INSIGHTS

 

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

 

7. INTELLECTUAL PROPERTY (IP) PORTFOLIO

 

7.1 PATENT QUALITY AND STRENGTH

7.2 PATENT FAMILIES

7.3 LICENSING AND COLLABORATIONS

7.4 COMPETITIVE LANDSCAPE

7.5 IP STRATEGY AND MANAGEMENT

7.6 OTHER

 

8. COST ANALYSIS BREAKDOWN

 

9. TECHNONLOGY ROADMAP

 

10. INNOVATION TRACKER AND STRATEGIC ANALYSIS

 

10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

 

10.1.1 JOINT VENTURES

10.1.2 MERGERS AND ACQUISITIONS

10.1.3 LICENSING AND PARTNERSHIP

10.1.4 TECHNOLOGY COLLABORATIONS

10.1.5 STRATEGIC DIVESTMENTS

 

10.2 NUMBER OF PRODUCTS IN DEVELOPMENT

10.3 STAGE OF DEVELOPMENT

10.4 TIMELINES AND MILESTONES

10.5 INNOVATION STRATEGIES AND METHODOLOGIES

10.6 RISK ASSESSMENT AND MITIGATION

10.7 FUTURE OUTLOOK

 

11. REGULATORY COMPLIANCE

 

11.1 REGULATORY AUTHORITIES

11.2 REGULATORY CLASSIFICATIONS

11.3 REGULATORY SUBMISSIONS

11.4 INTERNATIONAL HARMONIZATION

11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

11.6 REGULATORY CHALLENGES AND STRATEGIES

 

12. REIMBURSEMENT FRAMEWORK

 

13. OPPUTUNITY MAP ANALYSIS

 

14. VALUE CHAIN ANALYSIS

 

15. HEALTHCARE ECONOMY

 

15.1 HEALTHCARE EXPENDITURE

15.2 CAPITAL EXPENDITURE

15.3 CAPEX TRENDS

15.4 CAPEX ALLOCATION

15.5 FUNDING SOURCES

15.6 INDUSTRY BENCHMARKS

15.7 GDP RATION IN OVERALL GDP

15.8 HEALTHCARE SYSTEM STRUCTURE

15.9 GOVERNMENT POLICIES

15.10 ECONOMIC DEVELOPMENT

 

16. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, BY MODALITY

 

16.1 OVERVIEW

 

16.2 FOCUSED ULTRASOUND SURGERY (FUS)

 

16.2.1 SYSTEMS

16.2.2 PROBES 

16.2.3 ACCESSORIES AND CONSUMABLES

 

16.3 HEMOSTASIS

 

16.3.1 SYSTEMS

16.3.2 PROBES 

16.3.3 ACCESSORIES AND CONSUMABLES

 

16.4 THROMBOLYSIS

 

16.4.1 SYSTEMS

16.4.2 PROBES 

16.4.3 ACCESSORIES AND CONSUMABLES

 

16.5 TARGETED DRUG/GENE-DELIVERY

 

16.5.1 SYSTEMS

16.5.2 PROBES 

16.5.3 ACCESSORIES AND CONSUMABLES

 

16.6 TRANSCRANIAL BRAIN THERAPY

 

16.6.1 SYSTEMS

16.6.2 PROBES 

16.6.3 ACCESSORIES AND CONSUMABLES

 

16.7 OTHERS

 

17. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, BY PRODUCT

 

17.1 OVERVIEW

 

17.2 SYSTEMS

 

17.2.1 BY TYPE

 

17.2.1.1. ULTRASOUND- HIFU THERAPY SYSTEM

 

17.2.1.1.1. HANDHELD

17.2.1.1.2. CART/TROLLEY

17.2.1.1.3. OTHERS

 

17.2.1.2. MAGNETIC RESONANCE IMAGING- HIFU THERAPY SYSTEM

 

17.2.1.2.1. HANDHELD

17.2.1.2.2. CART/TROLLEY

17.2.1.2.3. OTHERS

 

17.2.2 BY OPERATION MODE

 

17.2.2.1. BATTERY POWERED

17.2.2.2. DIRECT POWERED

 

17.3 PROBES 

 

17.3.1 BY TYPE

 

17.3.1.1. LAPAROSCOPIC HIFU PROBE

17.3.1.2. TRANS-RECTAL HIFU PROBE

17.3.1.3. OTHERS

 

17.3.2 BY DESIGN

 

17.3.2.1. LONGITUDINAL

17.3.2.2. TRANSVERSE

17.3.2.3. OTHERS

 

17.3.3 BY FREQUENCY

 

17.3.3.1. 50HZ

17.3.3.2. 40HZ

17.3.3.3. 20HZ

17.3.3.4. OTHERS

 

17.4 ACCESSORIES AND CONSUMABLES

 

18. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, BY METHOD

 

18.1 OVERVIEW

18.2 NON-INVASIVE METHOD

18.3 MINIMAL-INVASIVE METHOD

19. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, BY APPLICATION

 

19.1 OVERVIEW

 

19.2 ONCOLOGY

 

19.2.1 PROSTATE CANCER

19.2.2 LIVER CANCER

19.2.3 PANCREATIC TUMOR

19.2.4 OTHERS

 

19.3 UTERINE FIBROIDS 

19.4 NEUROLOGICAL DISORDERS

19.5 MUSCULOSKELETAL

 

19.6 AESTHETICS

 

19.6.1 SKIN TIGHTENINGS

19.6.2 ANTI-AGING 

19.6.3 OTHERS

 

19.7 THYROID NODULE

19.8 OTHERS

 

20. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, BY END USER

 

20.1 OVERVIEW

 

20.2 HOSPITALS 

 

20.2.1 PRIVATE

 

20.2.1.1. TIER 1

 

20.2.2 SYSTEMS

20.2.3 PROBES 

 

20.2.4 ACCESSORIES AND CONSUMABLES

 

20.2.4.1. TIER 2

20.2.4.2. TIER 3

 

20.2.5 PUBLIC

 

20.2.5.1. TIER 1

20.2.5.2. TIER 2

20.2.5.3. TIER 3

 

20.3 REHAB CENTERS

 

20.3.1 SYSTEMS

20.3.2 PROBES 

20.3.3 ACCESSORIES AND CONSUMABLES

 

20.4 AMBULATORY CARE CENTERS

 

20.4.1 SYSTEMS

20.4.2 PROBES 

20.4.3 ACCESSORIES AND CONSUMABLES

20.5 MEDICAL SPAS AND AESTHATIC CENTERS

 

20.5.1 SYSTEMS

20.5.2 PROBES 

20.5.3 ACCESSORIES AND CONSUMABLES

 

20.6 ACADEMIC AND RESEARCH CENTERS

 

20.6.1 SYSTEMS

20.6.2 PROBES 

20.6.3 ACCESSORIES AND CONSUMABLES

 

20.7 OTHERS

 

21. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, BY DISTRIBUTION CHANNEL

 

21.1 OVERVIEW

21.2 DIRECT TENDERS

21.3 RETAIL SALES

21.4 ONLINE SALES

21.5 OTHERS

 

22. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, BY REGION

GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

 

22.1 NORTH AMERICA

 

22.1.1 U.S.

22.1.2 CANADA

22.1.3 MEXICO

 

22.2 EUROPE

 

22.2.1 GERMANY

22.2.2 FRANCE

22.2.3 U.K.

22.2.4 ITALY

22.2.5 SPAIN

22.2.6 RUSSIA

22.2.7 TURKEY

22.2.8 BELGIUM

22.2.9 NETHERLANDS

22.2.10 SWITZERLAND

22.2.11 REST OF EUROPE

 

22.3 ASIA-PACIFIC

 

22.3.1 JAPAN

22.3.2 CHINA

22.3.3 SOUTH KOREA

22.3.4 INDIA

22.3.5 AUSTRALIA

22.3.6 SINGAPORE

22.3.7 THAILAND

22.3.8 MALAYSIA

22.3.9 INDONESIA

22.3.10 PHILIPPINES

22.3.11 REST OF ASIA-PACIFIC

 

22.4 SOUTH AMERICA

 

22.4.1 BRAZIL

22.4.2 ARGENTINA

22.4.3 REST OF SOUTH AMERICA 

 

22.5 MIDDLE EAST AND AFRICA 

 

22.5.1 SOUTH AFRICA

22.5.2 SAUDI ARABIA

22.5.3 UAE

22.5.4 EGYPT

22.5.5 ISRAEL

22.5.6 REST OF MIDDLE EAST AND AFRICA

 

22.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES 

 

23. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, COMPANY LANDSCAPE

 

23.1 COMPANY SHARE ANALYSIS: GLOBAL

23.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

23.3 COMPANY SHARE ANALYSIS: EUROPE

23.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

23.5 MERGERS & ACQUISITIONS

23.6 NEW PRODUCT DEVELOPMENT & APPROVALS

23.7 EXPANSIONS

23.8 REGULATORY CHANGES

23.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

 

24. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, SWOT AND DBMR ANALYSIS

25. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, COMPANY PROFILE

 

25.1 EDAP TMS

 

25.1.1 COMPANY OVERVIEW

25.1.2 GEOGRAPHIC PRESENCE

25.1.3 REVENUE ANALYSIS

25.1.4 PRODUCT PORTFOLIO

25.1.5 RECENT DEVELOPEMENTS 

 

25.2 PROFOUND MEDICAL

 

25.2.1 COMPANY OVERVIEW

25.2.2 GEOGRAPHIC PRESENCE

25.2.3 REVENUE ANALYSIS

25.2.4 PRODUCT PORTFOLIO

25.2.5 RECENT DEVELOPEMENTS 

 

25.3 CHONGQING HAIFU MEDICAL TECHNOLOGY CO., LTD

 

25.3.1 COMPANY OVERVIEW

25.3.2 GEOGRAPHIC PRESENCE

25.3.3 REVENUE ANALYSIS

25.3.4 PRODUCT PORTFOLIO

25.3.5 RECENT DEVELOPEMENTS 

 

25.4 SONABLATE CORP.( SONACARE MEDICAL, LLC)

 

25.4.1 COMPANY OVERVIEW

25.4.2 GEOGRAPHIC PRESENCE

25.4.3 REVENUE ANALYSIS

25.4.4 PRODUCT PORTFOLIO

25.4.5 RECENT DEVELOPEMENTS 

 

25.5 SCINTICA INSTRUMENTATION, INC.

 

25.5.1 COMPANY OVERVIEW

25.5.2 GEOGRAPHIC PRESENCE

25.5.3 REVENUE ANALYSIS

25.5.4 PRODUCT PORTFOLIO

25.5.5 RECENT DEVELOPEMENTS 

 

25.6 ACOUSTIC MEDSYSTEMS, INC.

 

25.6.1 COMPANY OVERVIEW

25.6.2 GEOGRAPHIC PRESENCE

25.6.3 REVENUE ANALYSIS

25.6.4 PRODUCT PORTFOLIO

25.6.5 RECENT DEVELOPEMENTS 

25.7 ALPINION MEDICAL SYSTEMS CO., LTD

 

25.7.1 COMPANY OVERVIEW

25.7.2 GEOGRAPHIC PRESENCE

25.7.3 REVENUE ANALYSIS

25.7.4 PRODUCT PORTFOLIO

25.7.5 RECENT DEVELOPEMENTS 

 

25.8 THERACLION

 

25.8.1 COMPANY OVERVIEW

25.8.2 GEOGRAPHIC PRESENCE

25.8.3 REVENUE ANALYSIS

25.8.4 PRODUCT PORTFOLIO

25.8.5 RECENT DEVELOPEMENTS

 

25.9 INSIGHTEC

 

25.9.1 COMPANY OVERVIEW

25.9.2 GEOGRAPHIC PRESENCE

25.9.3 REVENUE ANALYSIS

25.9.4 PRODUCT PORTFOLIO

25.9.5 RECENT DEVELOPEMENTS

 

25.10 FUS INSTRUMENTS INC.

 

25.10.1 COMPANY OVERVIEW

25.10.2 GEOGRAPHIC PRESENCE

25.10.3 REVENUE ANALYSIS

25.10.4 PRODUCT PORTFOLIO

25.10.5 RECENT DEVELOPEMENTS 

 

25.11 ACOUSTIIC

 

25.11.1 COMPANY OVERVIEW

25.11.2 GEOGRAPHIC PRESENCE

25.11.3 REVENUE ANALYSIS

25.11.4 PRODUCT PORTFOLIO

25.11.5 RECENT DEVELOPEMENTS 

 

25.12 CARDIAWAVE

 

25.12.1 COMPANY OVERVIEW

25.12.2 GEOGRAPHIC PRESENCE

25.12.3 REVENUE ANALYSIS

25.12.4 PRODUCT PORTFOLIO

25.12.5 RECENT DEVELOPEMENTS 

 

25.13 EPISONICA

 

25.13.1 COMPANY OVERVIEW

25.13.2 GEOGRAPHIC PRESENCE

25.13.3 REVENUE ANALYSIS

25.13.4 PRODUCT PORTFOLIO

25.13.5 RECENT DEVELOPEMENTS 

 

25.14 ALPHEUS MEDICAL INC.

 

25.14.1 COMPANY OVERVIEW

25.14.2 GEOGRAPHIC PRESENCE

25.14.3 REVENUE ANALYSIS

25.14.4 PRODUCT PORTFOLIO

25.14.5 RECENT DEVELOPEMENTS 

 

25.15 ARRAYUS TECHNOLOGIES INC.

 

25.15.1 COMPANY OVERVIEW

25.15.2 GEOGRAPHIC PRESENCE

25.15.3 REVENUE ANALYSIS

25.15.4 PRODUCT PORTFOLIO

25.15.5 RECENT DEVELOPEMENTS 

 

25.16 BRAINSONIX CORP.

 

25.16.1 COMPANY OVERVIEW

25.16.2 GEOGRAPHIC PRESENCE

25.16.3 REVENUE ANALYSIS

25.16.4 PRODUCT PORTFOLIO

25.16.5 RECENT DEVELOPEMENTS 

 

25.17 CHANGJIANGYUAN TECHNOLOGY DEVELOPMENT CO., LTD

 

25.17.1 COMPANY OVERVIEW

25.17.2 GEOGRAPHIC PRESENCE

25.17.3 REVENUE ANALYSIS

25.17.4 PRODUCT PORTFOLIO

25.17.5 RECENT DEVELOPEMENTS 

 

25.18 IMGT CO.,LTD

 

25.18.1 COMPANY OVERVIEW

25.18.2 GEOGRAPHIC PRESENCE

25.18.3 REVENUE ANALYSIS

25.18.4 PRODUCT PORTFOLIO

25.18.5 RECENT DEVELOPEMENTS 

 

25.19 IMAGE GUIDED THERAPY, SA.

 

25.19.1 COMPANY OVERVIEW

25.19.2 GEOGRAPHIC PRESENCE

25.19.3 REVENUE ANALYSIS

25.19.4 PRODUCT PORTFOLIO

25.19.5 RECENT DEVELOPEMENTS 

25.20 INTERNATIONAL CARDIO CORP., LLC.

 

25.20.1 COMPANY OVERVIEW

25.20.2 GEOGRAPHIC PRESENCE

25.20.3 REVENUE ANALYSIS

25.20.4 PRODUCT PORTFOLIO

25.20.5 RECENT DEVELOPEMENTS 

 

25.21 MIANYANG SONIC ELECTRONIC

 

25.21.1 COMPANY OVERVIEW

25.21.2 GEOGRAPHIC PRESENCE

25.21.3 REVENUE ANALYSIS

25.21.4 PRODUCT PORTFOLIO

25.21.5 RECENT DEVELOPEMENTS 

 

25.22 SONOTHERA

 

25.22.1 COMPANY OVERVIEW

25.22.2 GEOGRAPHIC PRESENCE

25.22.3 REVENUE ANALYSIS

25.22.4 PRODUCT PORTFOLIO

25.22.5 RECENT DEVELOPEMENTS 

 

25.23 EYE TECH CARE

 

25.23.1 COMPANY OVERVIEW

25.23.2 GEOGRAPHIC PRESENCE

25.23.3 REVENUE ANALYSIS

25.23.4 PRODUCT PORTFOLIO

25.23.5 RECENT DEVELOPEMENTS 

 

25.24 SONIA THERAPEUTICS CO., LTD.

 

25.24.1 COMPANY OVERVIEW

25.24.2 GEOGRAPHIC PRESENCE

25.24.3 REVENUE ANALYSIS

25.24.4 PRODUCT PORTFOLIO

25.24.5 RECENT DEVELOPEMENTS 

 

25.25 TOOSONIX

 

25.25.1 COMPANY OVERVIEW

25.25.2 GEOGRAPHIC PRESENCE

25.25.3 REVENUE ANALYSIS

25.25.4 PRODUCT PORTFOLIO

25.25.5 RECENT DEVELOPEMENTS 

 

NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

 

26. RELATED REPORTS

 

27. CONCLUSION

 

28. QUESTIONNAIRE

 

29. ABOUT DATA BRIDGE MARKET RESEARCH